Automated Radiosynthesis Modules May Improve Cardiac Nuclear Imaging

Huge portions of the globally produced radiotracers find their origin within geographically centralized, commercial radiopharmaceutical manufacturing facilities or chemical laboratories. These facilities are limited in number and require expert supervision. There also is a considerable time gap between the preparation of these compounds and their transport and delivery to its end users at distant hospitals.

The time between manufacture and delivery of radiotracers is an issue, because most tracers have a short half-life and their in-vivo performance degradation is accelerated with the passage of time. Half-lives of many agents are measured in hours, and this often limits imaging to morning hours after the delivery of the tracers.

To read more please visit https://www.dicardiology.com/article/automated-radiosynthesis-modules-may-improve-cardiac-nuclear-imaging

Source: Diagnostic and Interventional Cardiology